0001325812-15-000026.txt : 20150422 0001325812-15-000026.hdr.sgml : 20150422 20150422163934 ACCESSION NUMBER: 0001325812-15-000026 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150227 FILED AS OF DATE: 20150422 DATE AS OF CHANGE: 20150422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howton David T CENTRAL INDEX KEY: 0001529297 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 15786054 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 edgardoc.xml PRIMARY DOCUMENT X0306 4/A 2015-02-27 2015-03-03 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001529297 Howton David T 215 FIRST STREET, SUITE 7 CAMBRIDGE MA 02142 0 1 0 0 SVP, General Counsel Incentive Stock Option (right to buy) 13.9 2015-02-27 4 A 0 5993.0 0.0 A 2025-02-27 Common Stock 5993 5993 D Non-Qualified Stock Option (right to buy) 13.9 2015-02-27 4 A 0 80007.0 0.0 A 2025-02-27 Common Stock 80007 80007 D The total grant originally reported has not changed, however the Incentive Stock Option/Non-Qualified Stock Option split of this stock option was incorrectly stated in the reporting person's original Form 4. 25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant. David Tyronne Howton 2015-04-22